Top

Published in:

01-10-2021 | Myocardial Infarction | Original Article

Adipose-Derived Mesenchymal Stem Cells-Derived Exosomes Carry MicroRNA-671 to Alleviate Myocardial Infarction Through Inactivating the TGFBR2/Smad2 Axis

Authors: Xue Wang, Yuhai Zhu, Chengcheng Wu, Wennan Liu, Yujie He, Qing Yang

Published in: Inflammation | Issue 5/2021

Abstract

Mesenchymal stem cells (MSCs) and their derived extracellular vesicles have been reported as promising tools for the management of heart disease. The aim of this study was to explore the function of adipose-derived MSCs (adMSCs)-derived exosomes (Exo) in the progression of myocardial infarction (MI) and the molecules involved. Mouse cardiomyocytes were treated with oxygen-glucose deprivation (OGD) to mimic an MI condition in vitro. The adMSCs-derived Exo were identified and administrated into the OGD-treated cardiomyocytes, and then the viability and apoptosis of cells, and the secretion of fibrosis- and inflammation-related cytokines in cells were determined. Differentially expressed microRNAs (miRNAs) in cells after Exo treatment were screened using a microarray analysis. The downstream molecules regulated by miR-671 were explored through bioinformatic analysis. Involvements of miR-671 and transforming growth factor beta receptor 2 (TGFBR2) in the exosome-mediated events were confirmed by rescue experiments. A murine model with MI was induced and treated with Exo for functional experiments in vivo. Compared to phosphate-buffered saline treatment, the Exo treatment significantly enhanced viability while reduced apoptosis of cardiomyocytes, and in reduced myocardial fibrosis and inflammation both in vitro and in vivo. miR-671 was significantly upregulated in cells after Exo treatment. Downregulation of miR-671 blocked the protective functions of Exo. miR-671 targeted TGFBR2 and suppressed phosphorylation of Smad2. Artificial downregulation of TGFBR2 enhanced viability of the OGD-treated cardiomyocytes. This study suggested that adMSC-derived exosomal miR-671 directly targets TGFBR2 and reduces Smad2 phosphorylation to alleviate MI-like symptoms both in vivo and in vitro.

Buja, L.M., B. Zehr, L. Lelenwa, E. Ogechukwu, B. Zhao, A. Dasgupta, and R.F. Barth. 2020. Clinicopathological complexity in the application of the universal definition of myocardial infarction. Cardiovascular Pathology 44: 107153. https://doi.org/10.1016/j.carpath.2019.107153.CrossRefPubMed

Thygesen, K., J.S. Alpert, A.S. Jaffe, B.R. Chaitman, J.J. Bax, D.A. Morrow, H.D. White, and Executive Group on behalf of the Joint European Society of Cardiology /American College of Cardiology /American Heart Association /World Heart Federation Task Force for the Universal Definition of Myocardial I. 2018. Fourth Universal Definition of Myocardial Infarction. Journal of the American College of Cardiology 72 (18): 2231–2264. https://doi.org/10.1016/j.jacc.2018.08.1038.CrossRefPubMed

Bejerano, T., S. Etzion, S. Elyagon, Y. Etzion, and S. Cohen. 2018. Nanoparticle delivery of miRNA-21 mimic to cardiac macrophages improves myocardial remodeling after myocardial infarction. Nano Letters 18 (9): 5885–5891. https://doi.org/10.1021/acs.nanolett.8b02578.CrossRefPubMed

Lippi, G., M. Franchini, and G. Cervellin. 2013. Diagnosis and management of ischemic heart disease. Seminars in Thrombosis and Hemostasis 39 (2): 202–213. https://doi.org/10.1055/s-0032-1333543.CrossRefPubMed

Katarzyna, R. 2017. Adult stem cell therapy for cardiac repair in patients after acute myocardial infarction leading to ischemic heart failure: An overview of evidence from the recent clinical trials. Current Cardiology Reviews 13 (3): 223–231. https://doi.org/10.2174/1573403X13666170502103833.CrossRefPubMedPubMedCentral

Song, Y., C. Zhang, J. Zhang, Z. Jiao, N. Dong, G. Wang, Z. Wang, and L. Wang. 2019. Localized injection of miRNA-21-enriched extracellular vesicles effectively restores cardiac function after myocardial infarction. Theranostics 9 (8): 2346–2360. https://doi.org/10.7150/thno.29945.CrossRefPubMedPubMedCentral

Pan, W., Y. Zhu, X. Meng, C. Zhang, Y. Yang, and Y. Bei. 2019. Immunomodulation by exosomes in myocardial infarction. Journal of Cardiovascular Translational Research 12 (1): 28–36. https://doi.org/10.1007/s12265-018-9836-7.CrossRefPubMed

Chen, G.H., J. Xu, and Y.J. Yang. 2017. Exosomes: promising sacks for treating ischemic heart disease? American Journal of Physiology. Heart and Circulatory Physiology 313 (3): H508–H523. https://doi.org/10.1152/ajpheart.00213.2017.CrossRefPubMed

Hong, P., H. Yang, Y. Wu, K. Li, and Z. Tang. 2019. The functions and clinical application potential of exosomes derived from adipose mesenchymal stem cells: A comprehensive review. Stem Cell Research & Therapy 10 (1): 242. https://doi.org/10.1186/s13287-019-1358-y.CrossRef

10.

Yuan, M.J., T. Maghsoudi, and T. Wang. 2016. Exosomes mediate the intercellular communication after myocardial infarction. International Journal of Medical Sciences 13 (2): 113–116. https://doi.org/10.7150/ijms.14112.CrossRefPubMedPubMedCentral

11.

Sun, T., Y.H. Dong, W. Du, C.Y. Shi, K. Wang, M.A. Tariq, J.X. Wang, and P.F. Li. 2017. The role of microRNAs in myocardial infarction: From molecular mechanism to clinical application. International Journal of Molecular Sciences 18 (4). https://doi.org/10.3390/ijms18040745.

12.

Zhong, Z., W. Zhong, Q. Zhang, Q. Zhang, Z. Yu, and H. Wu. 2020. Circulating microRNA expression profiling and bioinformatics analysis of patients with coronary artery disease by RNA sequencing. Journal of Clinical Laboratory Analysis 34 (1): e23020. https://doi.org/10.1002/jcla.23020.CrossRefPubMed

13.

Shinde, A.V., and N.G. Frangogiannis. 2014. Fibroblasts in myocardial infarction: a role in inflammation and repair. Journal of Molecular and Cellular Cardiology 70: 74–82. https://doi.org/10.1016/j.yjmcc.2013.11.015.CrossRefPubMed

14.

Derynck, R., and Y.E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 (6958): 577–584. https://doi.org/10.1038/nature02006.CrossRefPubMed

15.

Chen, Y., T. Li, Q. Gao, L.Y. Wang, and L.Q. Cui. 2018. MiR-1908 improves cardiac fibrosis after myocardial infarction by targeting TGF-beta1. European Review for Medical and Pharmacological Sciences 22 (7): 2061–2069. https://doi.org/10.26355/eurrev_201804_14736.CrossRefPubMed

16.

Wang, L., H. Shi, J.L. Huang, S. Xu, and P.P. Liu. 2020. Linggui Zhugan Decoction () inhibits ventricular remodeling after acute myocardial infarction in mice by suppressing TGF-beta1/Smad signaling pathway. Chinese Journal of Integrative Medicine 26 (5): 345–352. https://doi.org/10.1007/s11655-018-3024-0.CrossRefPubMed

17.

Shi, X., Q. Liu, N. Li, W. Tu, R. Luo, X. Mei, Y. Ma, W. Xu, H. Chu, S. Jiang, Z. Du, H. Zhao, L. Zhao, L. Jin, W. Wu, and J. Wang. 2018. MiR-3606-3p inhibits systemic sclerosis through targeting TGF-beta type II receptor. Cell Cycle 17 (16): 1967–1978. https://doi.org/10.1080/15384101.2018.1509621.CrossRefPubMedPubMedCentral

18.

Zhu, X., T. Zhang, Y. Zhang, H. Chen, J. Shen, X. Jin, J. Wei, E. Zhang, M. Xiao, Y. Fan, R. Mao, and G. Zhou. 2020. A super-enhancer controls TGF- beta signaling in pancreatic cancer through downregulation of TGFBR2. Cellular Signalling 66: 109470. https://doi.org/10.1016/j.cellsig.2019.109470.CrossRefPubMed

19.

Peng, Y., J.L. Zhao, Z.Y. Peng, W.F. Xu, and G.L. Yu. 2020. Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2. Cell Death & Disease 11 (5): 317. https://doi.org/10.1038/s41419-020-2545-6.CrossRef

20.

Li, X., X. Xue, Y. Sun, L. Chen, T. Zhao, W. Yang, Y. Chen, and Z. Zhang. 2019. MicroRNA-326-5p enhances therapeutic potential of endothelial progenitor cells for myocardial infarction. Stem Cell Research & Therapy 10 (1): 323. https://doi.org/10.1186/s13287-019-1413-8.CrossRef

21.

Sun, L., W. Zhu, P. Zhao, Q. Wang, B. Fan, Y. Zhu, Y. Lu, Q. Chen, J. Zhang, and F. Zhang. 2020. Long noncoding RNA UCA1 from hypoxia-conditioned hMSC-derived exosomes: A novel molecular target for cardioprotection through miR-873-5p/XIAP axis. Cell Death & Disease 11 (8): 696. https://doi.org/10.1038/s41419-020-02783-5.CrossRef

22.

Bai, W.W., Z.Y. Tang, T.C. Shan, X.J. Jing, P. Li, W.D. Qin, P. Song, B. Wang, J. Xu, Z. Liu, H.Y. Yu, Z.M. Ma, S.X. Wang, C. Liu, and T. Guo. 2020. Up-regulation of paired-related homeobox 2 promotes cardiac fibrosis in mice following myocardial infarction by targeting of Wnt5a. Journal of Cellular and Molecular Medicine 24 (3): 2319–2329. https://doi.org/10.1111/jcmm.14914.CrossRefPubMed

23.

Eid, R.A., M.A. Khalil, M.A. Alkhateeb, S.M. Eleawa, M.S.A. Zaki, A.F. El-Kott, M. Al-Shraim, F. El-Sayed, M.A. Eldeen, M.M. Bin-Meferij, K.M.E. Awaji, and A.S. Shatoor. 2020. Exendin-4 attenuates remodeling in the remote myocardium of rats after an acute myocardial infarction by activating beta-arrestin-2, protein phosphatase 2a, and glycogen synthase kinase-3 and inhibiting beta-catenin. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-020-07006-9.

24.

Xu, H.M., F.H. Sui, M.H. Sun, and G.L. Guo. 2019. Downregulated microRNA-224 aggravates vulnerable atherosclerotic plaques and vascular remodeling in acute coronary syndrome through activation of the TGF-beta/Smad pathway. Journal of Cellular Physiology 234 (3): 2537–2551. https://doi.org/10.1002/jcp.26945.CrossRefPubMed

25.

Peng, H., and A. Abdel-Latif. 2019. Cellular therapy for ischemic heart disease: An update. Advances in Experimental Medicine and Biology 1201: 195–213. https://doi.org/10.1007/978-3-030-31206-0_10.CrossRefPubMed

26.

Shafei, A.E., M.A. Ali, H.G. Ghanem, A.I. Shehata, A.A. Abdelgawad, H.R. Handal, K.A. Talaat, A.E. Ashaal, and A.S. El-Shal. 2017. Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction. The Journal of Gene Medicine 19 (12). https://doi.org/10.1002/jgm.2995.

27.

Zhang, F.B., and H.T. Yang. 2006. Plasticity of bone marrow mesenchymal stem cells differentiating into cardiomyocytes and the potential of cardiac therapeutics. Sheng Li Ke Xue Jin Zhan 37 (3): 199–204.PubMed

28.

Yoon, J., B.G. Min, Y.H. Kim, W.J. Shim, Y.M. Ro, and D.S. Lim. 2005. Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model. Acta Cardiologica 60 (3): 277–284. https://doi.org/10.2143/AC.60.3.2005005.CrossRefPubMed

29.

Jones, S., N. Horwood, A. Cope, and F. Dazzi. 2007. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. Journal of Immunology 179 (5): 2824–2831. https://doi.org/10.4049/jimmunol.179.5.2824.CrossRef

30.

Muguruma, Y., T. Yahata, H. Miyatake, T. Sato, T. Uno, J. Itoh, S. Kato, M. Ito, T. Hotta, and K. Ando. 2006. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 107 (5): 1878–1887. https://doi.org/10.1182/blood-2005-06-2211.CrossRefPubMed

31.

Biancone, L., S. Bruno, M.C. Deregibus, C. Tetta, and G. Camussi. 2012. Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrology, Dialysis, Transplantation 27 (8): 3037–3042. https://doi.org/10.1093/ndt/gfs168.CrossRefPubMed

32.

Borger, V., M. Bremer, R. Ferrer-Tur, L. Gockeln, O. Stambouli, A. Becic, and B. Giebel. 2017. Mesenchymal stem/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents. International Journal of Molecular Sciences 18 (7). https://doi.org/10.3390/ijms18071450.

33.

Ju, C., Y. Shen, G. Ma, Y. Liu, J. Cai, I.M. Kim, N.L. Weintraub, N. Liu, and Y. Tang. 2018. Transplantation of cardiac mesenchymal stem cell-derived exosomes promotes repair in ischemic myocardium. Journal of Cardiovascular Translational Research 11 (5): 420–428. https://doi.org/10.1007/s12265-018-9822-0.CrossRefPubMedPubMedCentral

34.

Lai, R.C., F. Arslan, M.M. Lee, N.S. Sze, A. Choo, T.S. Chen, M. Salto-Tellez, L. Timmers, C.N. Lee, R.M. El Oakley, G. Pasterkamp, D.P. de Kleijn, and S.K. Lim. 2010. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research 4 (3): 214–222. https://doi.org/10.1016/j.scr.2009.12.003.CrossRefPubMed

35.

Shi, Y., Y. Yang, Q. Guo, Q. Gao, Y. Ding, H. Wang, W. Xu, B. Yu, M. Wang, Y. Zhao, and W. Zhu. 2019. Exosomes derived from human umbilical cord mesenchymal stem cells promote fibroblast-to-myofibroblast differentiation in inflammatory environments and benefit cardioprotective effects. Stem Cells and Development 28 (12): 799–811. https://doi.org/10.1089/scd.2018.0242.CrossRefPubMed

36.

Zhu, L.P., T. Tian, J.Y. Wang, J.N. He, T. Chen, M. Pan, L. Xu, H.X. Zhang, X.T. Qiu, C.C. Li, K.K. Wang, H. Shen, G.G. Zhang, and Y.P. Bai. 2018. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction. Theranostics 8 (22): 6163–6177. https://doi.org/10.7150/thno.28021.CrossRefPubMedPubMedCentral

37.

Wen, Z., S. Zheng, C. Zhou, W. Yuan, J. Wang, and T. Wang. 2012. Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: MicroRNAs as novel regulators. Journal of Cellular and Molecular Medicine 16 (4): 657–671. https://doi.org/10.1111/j.1582-4934.2011.01471.x.CrossRefPubMedPubMedCentral

38.

Chen, Y., Y. Zhao, W. Chen, L. Xie, Z.A. Zhao, J. Yang, Y. Chen, W. Lei, and Z. Shen. 2017. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction. Stem Cell Research & Therapy 8 (1): 268. https://doi.org/10.1186/s13287-017-0722-z.CrossRef

39.

Zhang, X., G. Xin, and D. Sun. 2018. Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy. Experimental and Therapeutic Medicine 16 (3): 2420–2432. https://doi.org/10.3892/etm.2018.6458.CrossRefPubMedPubMedCentral

40.

Zhang, B., M. Sun, J. Wang, C. Ma, T. Hao, G. Liu, G. Bao, and Y. Zhu. 2019. MiR-671 ameliorates the progression of osteoarthritis in vitro and in vivo. Pathology, Research and Practice 215 (7): 152423. https://doi.org/10.1016/j.prp.2019.04.015.

41.

Lakshmipathy, U., and R.P. Hart. 2008. Concise review: MicroRNA expression in multipotent mesenchymal stromal cells. Stem Cells 26 (2): 356–363. https://doi.org/10.1634/stemcells.2007-0625.CrossRefPubMed

42.

Liu, S., J. Iaria, R.J. Simpson, and H.J. Zhu. 2018. Ras enhances TGF-beta signaling by decreasing cellular protein levels of its type II receptor negative regulator SPSB1. Cell Communication and Signaling: CCS 16 (1): 10. https://doi.org/10.1186/s12964-018-0223-4.CrossRefPubMedPubMedCentral

43.

Pan, L.X., and W. Ding. 2020. LncRNA HAGLR accelerates femoral neck fracture healing through negatively regulating miRNA-19a-3p. European Review for Medical and Pharmacological Sciences 24 (8): 4080–4087. https://doi.org/10.26355/eurrev_202004_20984.CrossRefPubMed

44.

Chen, P., R. Wu, W. Zhu, Z. Jiang, Y. Xu, H. Chen, Z. Zhang, H. Chen, L. Zhang, H. Yu, J. Wang, and X. Hu. 2014. Hypoxia preconditioned mesenchymal stem cells prevent cardiac fibroblast activation and collagen production via leptin. PLoS ONE 9 (8): e103587. https://doi.org/10.1371/journal.pone.0103587.CrossRefPubMedPubMedCentral

45.

Zhou, F.Q., X.F. Zhao, F.Y. Liu, S.S. Wang, H.L. Hu, and Y. Fang. 2019. MiR-101a attenuates myocardial cell apoptosis in rats with acute myocardial infarction via targeting TGF-beta/JNK signaling pathway. European Review for Medical and Pharmacological Sciences 23 (10): 4432–4438. https://doi.org/10.26355/eurrev_201905_17952.CrossRefPubMed

46.

Ding, Y.F., Y.R. Peng, J. Li, H. Shen, M.Q. Shen, and T.H. Fang. 2013. Gualou Xiebai Decoction prevents myocardial fibrosis by blocking TGF-beta/Smad signalling. The Journal of Pharmacy and Pharmacology 65 (9): 1373–1381. https://doi.org/10.1111/jphp.12102.CrossRefPubMed

47.

He, Y., X. Zhou, X. Zheng, and X. Jiang. 2013. Exogenous high-mobility group box 1 protein prevents postinfarction adverse myocardial remodeling through TGF-beta/Smad signaling pathway. Journal of Cellular Biochemistry 114 (7): 1634–1641. https://doi.org/10.1002/jcb.24505.CrossRefPubMed

48.

Lin, Y., F. Zhang, X.F. Lian, W.Q. Peng, and C.Y. Yin. 2019. Mesenchymal stem cell-derived exosomes improve diabetes mellitus-induced myocardial injury and fibrosis via inhibition of TGF-beta1/Smad2 signaling pathway. Cellular and Molecular Biology (Noisy-le-Grand, France) 65 (7): 123–126.CrossRef

Title: Adipose-Derived Mesenchymal Stem Cells-Derived Exosomes Carry MicroRNA-671 to Alleviate Myocardial Infarction Through Inactivating the TGFBR2/Smad2 Axis
Authors: Xue Wang
Yuhai Zhu
Chengcheng Wu
Wennan Liu
Yujie He
Qing Yang
Publication date: 01-10-2021
Publisher: Springer US
Keyword: Myocardial Infarction
Published in: Inflammation / Issue 5/2021
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-021-01460-9

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2021

Atractylon Treatment Attenuates Pulmonary Fibrosis via Regulation of the mmu_circ_0000981/miR-211-5p/TGFBR2 Axis in an Ovalbumin-Induced Asthma Mouse Model

KRN7000 Reduces Airway Inflammation via Natural Killer T Cells in Obese Asthmatic Mice

Circular RNA circHIPK3 Activates Macrophage NLRP3 Inflammasome and TLR4 Pathway in Gouty Arthritis via Sponging miR-561 and miR-192

Interferon Gamma-Mediated Oxidative Stress Induces Apoptosis, Neuroinflammation, Zinc Ion Influx, and TRPM2 Channel Activation in Neuronal Cell Line: Modulator Role of Curcumin

Downregulation of Cathepsin B Reduces Proliferation and Inflammatory Response and Facilitates Differentiation in Human HaCaT Keratinocytes, Ameliorating IL-17A and SAA-Induced Psoriasis-Like Lesion

Correction to: Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage